These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 36226731)

  • 1. The prognostic marker elastin correlates with epithelial-mesenchymal transition and vimentin-positive fibroblasts in gastric cancer.
    Fang T; Zhang L; Yin X; Wang Y; Zhang X; Bian X; Jiang X; Yang S; Xue Y
    J Pathol Clin Res; 2023 Jan; 9(1):56-72. PubMed ID: 36226731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prognostic marker LTBP1 is associated with epithelial mesenchymal transition and can promote the progression of gastric cancer.
    Jiang X; Yin S; Yin X; Wang Y; Fang T; Yang S; Bian X; Li G; Xue Y; Zhang L
    Funct Integr Genomics; 2024 Feb; 24(1):30. PubMed ID: 38358412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer-associated fibroblast expression of glutamine fructose-6-phosphate aminotransferase 2 (GFPT2) is a prognostic marker in gastric cancer.
    Yang S; Li G; Yin X; Wang Y; Jiang X; Bian X; Fang T; Yin S; Zhang L; Xue Y
    J Pathol Clin Res; 2023 Sep; 9(5):391-408. PubMed ID: 37395335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PRRX1 promotes lymph node metastasis of gastric cancer by regulating epithelial-mesenchymal transition.
    Yao J; Zhang Y; Xia Y; Zhu C; Wen X; Liu T; Da M
    Medicine (Baltimore); 2021 Feb; 100(6):e24674. PubMed ID: 33578599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
    Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
    Front Immunol; 2022; 13():947802. PubMed ID: 36405735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of miRNA-214 in cancer-associated fibroblasts contributes to migration and invasion of gastric cancer cells through targeting FGF9 and inducing EMT.
    Wang R; Sun Y; Yu W; Yan Y; Qiao M; Jiang R; Guan W; Wang L
    J Exp Clin Cancer Res; 2019 Jan; 38(1):20. PubMed ID: 30646925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential association of LOXL1 with peritoneal dissemination in gastric cancer possibly via promotion of EMT.
    Hu Q; Masuda T; Kuramitsu S; Tobo T; Sato K; Kidogami S; Nambara S; Ueda M; Tsuruda Y; Kuroda Y; Ito S; Oki E; Mori M; Mimori K
    PLoS One; 2020; 15(10):e0241140. PubMed ID: 33095806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical significance of vimentin-expressing gastric cancer cells in bone marrow.
    Iwatsuki M; Mimori K; Fukagawa T; Ishii H; Yokobori T; Sasako M; Baba H; Mori M
    Ann Surg Oncol; 2010 Sep; 17(9):2526-33. PubMed ID: 20358301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased expression of LKB1 is associated with epithelial-mesenchymal transition and led to an unfavorable prognosis in gastric cancer.
    Hu M; Zhao T; Liu J; Zou Z; Xu Q; Gong P; Guo H
    Hum Pathol; 2019 Jan; 83():133-139. PubMed ID: 30171989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of altering epithelial-mesenchymal transition in metastatic lymph nodes of gastric cancer.
    Okubo K; Uenosono Y; Arigami T; Yanagita S; Matsushita D; Kijima T; Amatatsu M; Uchikado Y; Kijima Y; Maemura K; Natsugoe S
    Gastric Cancer; 2017 Sep; 20(5):802-810. PubMed ID: 28247164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased expression of the long noncoding RNA LINC00261 indicate poor prognosis in gastric cancer and suppress gastric cancer metastasis by affecting the epithelial-mesenchymal transition.
    Fan Y; Wang YF; Su HF; Fang N; Zou C; Li WF; Fei ZH
    J Hematol Oncol; 2016 Jul; 9(1):57. PubMed ID: 27439973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyr61/CCN1 overexpression induces epithelial-mesenchymal transition leading to laryngeal tumor invasion and metastasis and poor prognosis.
    Liu Y; Zhou YD; Xiao YL; Li MH; Wang Y; Kan X; Li QY; Lu JG; Jin DJ
    Asian Pac J Cancer Prev; 2015; 16(7):2659-64. PubMed ID: 25854342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of EphA2 correlates with epithelial-mesenchymal transition-related proteins in gastric cancer and their prognostic importance for postoperative patients.
    Hou F; Yuan W; Huang J; Qian L; Chen Z; Ge J; Wu S; Chen J; Wang J; Chen Z
    Med Oncol; 2012 Dec; 29(4):2691-700. PubMed ID: 22189617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of Stathmin1 expression and epithelial-mesenchymal transition in curatively resected gastric cancer.
    Ke B; Guo XF; Li N; Wu LL; Li B; Zhang RP; Liang H
    Mol Clin Oncol; 2019 Feb; 10(2):214-222. PubMed ID: 30680197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD146 expression correlates with epithelial-mesenchymal transition markers and a poor prognosis in gastric cancer.
    Liu WF; Ji SR; Sun JJ; Zhang Y; Liu ZY; Liang AB; Zeng HZ
    Int J Mol Sci; 2012; 13(5):6399-6406. PubMed ID: 22754372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metastasis Related Epithelial-Mesenchymal Transition Signature Predicts Prognosis and Response to Immunotherapy in Gastric Cancer.
    Song J; Wei R; Huo S; Gao J; Liu X
    Front Immunol; 2022; 13():920512. PubMed ID: 35769483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Slug expression is useful for predicting lymph node metastasis and survival in patients with gastric cancer.
    Lee HH; Lee SH; Song KY; Na SJ; O JH; Park JM; Jung ES; Choi MG; Park CH
    BMC Cancer; 2017 Oct; 17(1):670. PubMed ID: 28974196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of SATB1 correlates with epithelial-mesenchymal transition and lymphatic metastasis in gastric cancer.
    Xiao T; Jie Z; Zou J; Fu L
    Ann Diagn Pathol; 2023 Feb; 62():152074. PubMed ID: 36495733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elastin is a key factor of tumor development in colorectal cancer.
    Li J; Xu X; Jiang Y; Hansbro NG; Hansbro PM; Xu J; Liu G
    BMC Cancer; 2020 Mar; 20(1):217. PubMed ID: 32171282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of epithelial-mesenchymal transition markers in clear cell renal cell carcinoma.
    Xu H; Xu WH; Ren F; Wang J; Wang HK; Cao DL; Shi GH; Qu YY; Zhang HL; Ye DW
    Aging (Albany NY); 2020 Jan; 12(1):866-883. PubMed ID: 31915310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.